TRANSGENE (EPA:TNG) | WebDisclosure

Basculer en Français

10826	Companies
234866	Keywords
163735	Articles
125716	Press releases

Home
Companies
TRANSGENE

PRESS RELEASE

published on 06/01/2025 at 19:15, 1 year 2 months ago

Transgene and NEC Present Durable Disease-Free Survival and Sustained T Cell Responses at 24 Months with Individualized Cancer Vaccine TG4050
Transgene and NEC reveal positive data on TG4050 cancer vaccine, demonstrating durable disease-free survival and sustained T cell responses at 24 months in HPV-negative head and neck cancer. Conference call on June 6, 2025

Cancer Vaccine Transgene TG4050 ASCO 2025 NEC
BRIEF

published on 05/22/2025 at 17:50, 1 year 2 months ago

Transgene to Present Phase I Data on Cancer Vaccine TG4050 at ASCO 2025

Cancer Vaccine Transgene TG4050 ASCO 2025 Phase I Data
BRIEF

published on 05/22/2025 at 17:50, 1 year 2 months ago

Transgene présentera les données de phase I sur le vaccin contre le cancer TG4050 à l'ASCO 2025

Vaccin Contre Le Cancer Transgene TG4050 ASCO 2025 Données De La Phase I
PRESS RELEASE

published on 05/22/2025 at 17:45, 1 year 2 months ago

Transgene to Present 24-month Disease-Free Survival Data from All Patients in Phase I Part of Trial of Individualized Cancer Vaccine, TG4050, at ASCO 2025
Transgene to present 24-month disease-free survival data from all patients in Phase I part of trial of individualized cancer vaccine, TG4050, at ASCO 2025

Cancer Vaccine Transgene TG4050 ASCO 2025 Disease-free Survival
BRIEF

published on 04/10/2025 at 20:20, 1 year 4 months ago

Mise à disposition du Document d’Enregistrement Universel 2024 par Transgene

AMF Immunothérapie Responsabilité Sociale Document D'enregistrement Transgene
BRIEF

published on 04/10/2025 at 20:20, 1 year 4 months ago

Transgene makes available the 2024 Universal Registration Document

AMF Social Responsibility Immunotherapy Registration Document Transgene
PRESS RELEASE

published on 04/10/2025 at 20:15, 1 year 4 months ago

Mise à disposition du Document d’Enregistrement Universel (DEU) 2024 de Transgene
Transgene annonce la mise à disposition de son Document d'Enregistrement Universel 2024 auprès de l'AMF, contenant des informations financières et RSE

AMF RSE Informations Financières Document D'Enregistrement Universel Transgene
PRESS RELEASE

published on 04/10/2025 at 20:15, 1 year 4 months ago

Availability of Transgene’s 2024 Universal Registration Document (URD)
Transgene announces availability of its 2024 Universal Registration Document (URD) containing financial reports and ESG factors. French & English versions can be accessed online

Financial Reports Transgene ESG Factors 2024 Universal Registration Document French Version
BRIEF

published on 03/27/2025 at 17:50, 1 year 4 months ago

Transgene : avancées majeures et perspectives 2025

Immunothérapie Cancer De La Tête Et Du Cou Résultats Financiers 2024 Vaccin TG4050 Plateforme Myvac®
BRIEF

published on 03/27/2025 at 17:50, 1 year 4 months ago

Transgene: major advances and outlook for 2025

Immunotherapy Head And Neck Cancer 2024 Financial Results TG4050 Vaccine Myvac® Platform

Accesswire

Published on 08/12/2026 at 15:42, 3 hours 14 minutes ago

Critical Elements 10,000-Meter Summer Drill Program at Rose West Resumes with Positive Results
Published on 08/12/2026 at 15:42, 3 hours 14 minutes ago

Critical Elements redémarre son programme de forage estival de 10 000 mètres à Rose Ouest avec des résultats positifs
Published on 08/12/2026 at 15:00, 3 hours 56 minutes ago

Karbon-X and Core Energy Sign Letter of Intent to Explore Commercial EV Charging Infrastructure in South America
Published on 08/12/2026 at 14:45, 4 hours 11 minutes ago

Lobe Sciences Ltd. Announces Non-Brokered Private Placement
Published on 08/12/2026 at 14:30, 4 hours 26 minutes ago

Recent Corporate Events Recap

View all ACCESSWIRE

EQS Group

Published on 08/12/2026 at 18:29, 27 minutes ago

Designated Persons Notifications
Published on 08/12/2026 at 18:29, 27 minutes ago

Designated Persons Notifications
Published on 08/12/2026 at 18:17, 39 minutes ago

EQS-Adhoc: Gateway Real Estate AG resolves segment change from the regulated market (Prime Standard) to the Scale segment of the open market (Freiverkehr) on the Frankfurt Stock Exchange
Published on 08/12/2026 at 18:15, 41 minutes ago

Shelly Group Delivers Strong Revenue and Earnings Growth in the First Six Months of 2026
Published on 08/12/2026 at 18:00, 56 minutes ago

ABIVAX: Nombre d’actions composant le capital social et nombre total de droits de vote au 31.07.26

Les Echos

Published on 08/11/2026 at 17:45, 1 day 1 hour ago

DAMARTEX / Droits de vote bruts et réels au 31 juillet 2026
Published on 08/11/2026 at 17:40, 1 day 1 hour ago

Infotel : Déclaration des transactions sur actions propres réalisées du 3 au 7 août 2026 dans le cadre du programme de rachat d’actions
Published on 08/10/2026 at 18:00, 2 days ago

AXA: Information relating to the number of voting rights and shares making up the share capital on 31/07/2026
Published on 08/10/2026 at 18:00, 2 days ago

AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 31/07/2026
Published on 08/10/2026 at 17:45, 2 days 1 hour ago

Weekly share buyback

View all LES ECHOS COMFI WIRE